# POVIDONE K30 URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid0025941 Categories: beauty, cleaning, food, industrial, pharma Functions: Anti-static agent, Binder, Dispersing agent, Emulsifier, Film former, Fixing agent (mordant), Fragrance, Hair fixative, Pharmaceutical excipient, Stabilizing agent, Viscosity modifier, anti-irritant Identifier: DTXSID0025941 > POVIDONE K30 is used as anti-static agent / binder. EPA CPDat observed this chemical in 1957 composition records across product categories including Specialty occupational products, Raw materials, Food and drug. Assessed from 135 sources. ## Safety assessment - Chemical concern: not yet assessed - Rationale: EPA CPDat observed this chemical in 1957 composition records across product categories including Specialty occupational products, Raw materials, Food and drug. ## Regulatory status - US: commercial use observed — EPA CPDat observed this chemical in 1957 composition records across product categories including Specialty occupational products, Raw materials, Food and drug. EPA CPDat classifies this chemical for functional uses including anti-irritant, Film former, Anti-static agent. - US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: NA - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 0.2 %w/v - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 1.8 %w/v - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 1.8 %w/v - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.6 %w/v - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 300 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 10.03 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Potency: NA - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE PELLETS; Maximum daily exposure: 32 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 56 mg - US: inactive ingredient database — Route: ORAL; Dosage form: DROPS; Potency: NA - US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION, EXTENDED RELEASE; Potency: NA - US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: 35 mg/5ml - US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 3000 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Potency: 20 mg/5ml - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 216 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 48 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 49.2 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 53 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 101 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 240 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 17 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Potency: 2 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Potency: 15.03 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TROCHE; Potency: 30 mg - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: IMPLANT; Potency: 6 mg - US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 6 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 41 mg - US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: NA - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 648 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 0.2 %w/v - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 600 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION; Potency: 0.08 %w/v - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION, CONCENTRATE; Maximum daily exposure: 1000 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 173 mg - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 20 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 20 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 130 mg - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: 0.5 %w/v - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: SUSPENSION; Potency: 0.5 %w/v - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 200 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 90 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 67 mg - US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Potency: 0.27 mg - US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 126 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Potency: 500 mg/5ml - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 640 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 0.45 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 240 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 49 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 200 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 163 mg - US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 1 mg - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 0.59 %w/v - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 42 mg - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 4 mg - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Maximum daily exposure: 14 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 540 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Maximum daily exposure: 15 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 227 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE PELLETS; Maximum daily exposure: 178 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 120 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 101 mg - US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 202 mg - US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, EFFERVESCENT; Potency: 40 mg - US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 120 mg - US: inactive ingredient database — Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 700 mg - US: inactive ingredient database — Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 24 mg - US: inactive ingredient database — Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 378 mg - US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 2832 mg - US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 257 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 300 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 148 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 474 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 2828 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 245 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 12 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 160 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 516 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE PARTICLES; Maximum daily exposure: 70 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 368 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 245 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 45 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 462 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 71 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TROCHE; Maximum daily exposure: 175 mg - US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 7 mg - US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 30 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 1.9 %w/w - US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Maximum daily exposure: 16 mg - US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: SYSTEM; Maximum daily exposure: 15 mg - US: inactive ingredient database — Route: VAGINAL; Dosage form: INSERT; Maximum daily exposure: 147 mg - US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 2 mg - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.3 %w/v - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 1.2 %w/w - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Maximum daily exposure: 4 mg - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 1.5 %w/v - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 270 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 137 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 118 mg - US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 140 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 2 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 966 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 9.77 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 192 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 498 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 128 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 120 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 280 mg - US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: SOLUTION; Maximum daily exposure: 100 mg - US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: SYSTEM; Potency: 20 mg - US: marketed drug occurrence — FDA NDC lists this ingredient in 53 active drug products and 54 total products. - US: listed in openFDA substance — openFDA substance registry classifies this ingredient as polymer. - US: listed in openFDA substance — openFDA substance registry classifies this ingredient as mixture. _Assessed by Greenveil._